NCT06846190 Modified Constraint Induced Movement Therapy Versus Virtual Reality Training in Children With Cerebral Palsy
| NCT ID | NCT06846190 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Hemiplegic Cerebral Palsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-02-15 |
| Primary Completion | 2025-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-02-15 with a primary completion date of 2025-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Children with hemiplegic cerebral palsy (CP) are characterized by motor impairments mainly lateralized to one side of the body, with greater upper limb than lower limb involvement; these impairments may further limit the daily activities and school participation of children with hemiplegic CP. For the improvement of activity limitations in hemipelagic cerebral palsy children will take 20 hemiplegic cerebral palsy children with the age of 5-16 year all participants will be randomly assign and use modified Constraint induced movement therapy and virtual reality techniques. mCIMT and Hot pack will be given to group I and unaffected hand will immobilized by a volar resting splint extending from finger tips to the proximal forearm. Use splint every day for at least 5 waking hours individualized, 18-hour program of mCIMT every other day, 3 times per week during a 4-week period. Each modified CIMT session continued for 1.5 hours will give to group I on the other hand VR and Hot pack will give to group II and 18-hour VR program, every other day, 3 times per week for 4 weeks will give Each VR session continued for 1.5 hours. Then evaluate both groups on follow up. All the data will be collected from Rising Sun Institute by using ABILHAND-KIDS questionnaire and Children's hand-use experience questionnaire. The reliability and validity of tools and mentioned. The duration of study will be 6-months. Data will be analyzed with the help of SPSS 27
Eligibility Criteria
Inclusion Criteria: * Age range between 5 to 16 years of age. * Medical diagnosis of spastic hemiparetic CP. * At least 20◦wrist and 10◦ active finger extension from full flexion. * More movement deficits in 1 upper extremity (less than 2.5 on the Amount of Use scale (AOU) on the Pediatric Motor Activity Log (PMAL)). * Muscle tone less than 3 on the Modified Ashworth Scale. * Normal or corrected-to-normal vision and hearing. * Classified level I, II, or III of the Manual Ability Classification System ( MACS) for Children with CP Exclusion Criteria: * Health problems not associated with CP. * Seizure hemispatial neglect. * Orthopaedic surgery on the involved upper extremity. * Botulinum toxin therapy for the affected upper extremity within the past 6 months or within the study period. * Balance problems
Contact & Investigator
Maria Amjad, MS-PPT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06846190 clinical trial?
This trial is open to participants of all sexes, aged 6 Years or older, up to 12 Years, studying Hemiplegic Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06846190 currently recruiting?
Yes, NCT06846190 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06846190 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06846190 clinical trial?
NCT06846190 is sponsored by Riphah International University. The principal investigator is Maria Amjad, MS-PPT at Riphah International University. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.